CXCL12 and neoplasm: Located primarily around the tumor bulk, myCAFs expressed strong α-SMA with a highly matrix-producing, contractile phenotype, while iCAFs were more remote from the tumor margins, in the desmoplastic area of the tumor, and characterized by the expression of an immunomodulatory secretome including IL-6 and CXCL12 [12,74].